{"id":"https://openalex.org/W2011433383","doi":"https://doi.org/10.1089/jir.1989.9.435","title":"Phase I Study of a Combination of Recombinant Tumor Necrosis Factor-\u03b1 and Recombinant Interferon-\u03b3 in Cancer Patients","display_name":"Phase I Study of a Combination of Recombinant Tumor Necrosis Factor-\u03b1 and Recombinant Interferon-\u03b3 in Cancer Patients","publication_year":1989,"publication_date":"1989-08-01","ids":{"openalex":"https://openalex.org/W2011433383","doi":"https://doi.org/10.1089/jir.1989.9.435","mag":"2011433383","pmid":"https://pubmed.ncbi.nlm.nih.gov/2502584"},"language":"en","primary_location":{"id":"doi:10.1089/jir.1989.9.435","doi":"https://doi.org/10.1089/jir.1989.9.435","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jir.1989.9.435","pdf_url":null,"source":{"id":"https://openalex.org/S2755320784","display_name":"Journal of Interferon Research","issn_l":"0197-8357","issn":["0197-8357","2332-4007"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Interferon Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"RAZELLE KURZROCK","raw_affiliation_strings":["Department of Clinical Immunology, University of Texas, M.D. Anderson Cancer Center, Houston 77030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Immunology, University of Texas, M.D. Anderson Cancer Center, Houston 77030","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050866878","display_name":"Bruce A. Feinberg","orcid":"https://orcid.org/0000-0001-9267-9994","observed_orcids":["https://orcid.org/0000-0001-9267-9994"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"BRUCE FEINBERG","raw_affiliation_strings":["","University of Texas, M. D. Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"University of Texas, M. D. Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011529063","display_name":"Moshe Talpaz","orcid":"https://orcid.org/0000-0003-3361-3981","observed_orcids":["https://orcid.org/0000-0003-3361-3981"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"MOSHE TALPAZ","raw_affiliation_strings":["","University of Texas, M. D. Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"University of Texas, M. D. Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110016065","display_name":"Samuel R. Saks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"SAMUEL SAKS","raw_affiliation_strings":["","GENENTECH,INC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"GENENTECH,INC","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111569636","display_name":"Jordan U. Gutterman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JORDAN U. GUTTERMAN","raw_affiliation_strings":["","University of Texas, M. D. Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"University of Texas, M. D. Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9501,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.73944346,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"9","issue":"4","first_page":"435","last_page":"444"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.39890000224113464,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.39890000224113464,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.1671999990940094,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.05260000005364418,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recombinant-interferon-gamma","display_name":"recombinant interferon-gamma","score":0.9769999980926514},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.8510000109672546},{"id":"https://openalex.org/keywords/metastatic-cancer","display_name":"metastatic cancer","score":0.9940000176429749},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7170000076293945},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9459999799728394},{"id":"https://openalex.org/keywords/constitutional-symptoms","display_name":"constitutional symptoms","score":0.7950000166893005},{"id":"https://openalex.org/keywords/lipid-metabolism","display_name":"lipid metabolism","score":0.6669999957084656},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.8399999737739563},{"id":"https://openalex.org/keywords/cholesterol","display_name":"cholesterol","score":0.7929999828338623},{"id":"https://openalex.org/keywords/granulocytopenia","display_name":"granulocytopenia","score":0.8180000185966492},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9490000009536743},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.6510000228881836}],"concepts":[{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.8363011479377747},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5796936750411987},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.575884997844696},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4922398626804352},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48730385303497314},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40845972299575806},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.350861132144928},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3303336501121521},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28974562883377075},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27326861023902893},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1241828203201294},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08392855525016785}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000917","descriptor_name":"Antibody Formation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/jir.1989.9.435","doi":"https://doi.org/10.1089/jir.1989.9.435","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jir.1989.9.435","pdf_url":null,"source":{"id":"https://openalex.org/S2755320784","display_name":"Journal of Interferon Research","issn_l":"0197-8357","issn":["0197-8357","2332-4007"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Interferon Research","raw_type":"journal-article"},{"id":"pmid:2502584","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2502584","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of interferon research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306142","display_name":"John D. and Catherine T. MacArthur Foundation","ror":"https://ror.org/00dxczh48"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1491325575","https://openalex.org/W1606300676","https://openalex.org/W1968713831","https://openalex.org/W1989783048","https://openalex.org/W1995628336","https://openalex.org/W1997652060","https://openalex.org/W2002209097","https://openalex.org/W2004556731","https://openalex.org/W2012739094","https://openalex.org/W2043008373","https://openalex.org/W2048540725","https://openalex.org/W2057123987","https://openalex.org/W2066957976","https://openalex.org/W2075813138","https://openalex.org/W2080856124","https://openalex.org/W2083726090","https://openalex.org/W2144360148","https://openalex.org/W2150858574","https://openalex.org/W2171612134","https://openalex.org/W2182859076","https://openalex.org/W2337803710","https://openalex.org/W2339932366","https://openalex.org/W2345485357","https://openalex.org/W2418766581"],"related_works":["https://openalex.org/W2087530395","https://openalex.org/W1919752579","https://openalex.org/W2173422486","https://openalex.org/W2331953162","https://openalex.org/W2019554419","https://openalex.org/W2254933028","https://openalex.org/W2410603193","https://openalex.org/W2093612034","https://openalex.org/W1983357325","https://openalex.org/W2028405879"],"abstract_inverted_index":{"Combinations":[0],"of":[1,21,54,74,78,93,123,143,169,181,196,202,241,251,272],"tumor":[2],"necrosis":[3],"factor-alpha":[4],"(TNF-alpha)":[5],"and":[6,25,39,69,115,159,177,217,234,274],"interferon-gamma":[7],"(IFN-gamma)":[8],"demonstrate":[9],"synergistic":[10],"antiproliferative":[11],"activity":[12],"in":[13,29,155,166,178,215],"vitro.":[14],"Therefore,":[15],"we":[16],"initiated":[17],"a":[18,52,135,163,249],"clinical":[19],"study":[20,263],"recombinant":[22],"TNF-alpha":[23],"(rTNF-alpha)":[24],"rIFN-gamma":[26,40,275],"combination":[27,276],"therapy":[28,94,231],"humans.":[30],"Twenty-five":[31],"patients":[32,80,145,244,258],"with":[33,199,204],"metastatic":[34],"cancer":[35],"received":[36],"both":[37],"rTNF-alpha":[38,197,273],"by":[41,162],"intramuscular":[42],"injection":[43],"for":[44,51,248,268],"5":[45],"consecutive":[46],"days":[47],"every":[48],"2":[49,79],"weeks":[50,253],"total":[53],"4":[55],"weeks.":[56],"The":[57,189],"dose":[58,86,99,106,128,192],"levels":[59],"were":[60,81,117,160],"5/5,":[61],"10/5,":[62],"10/10,":[63],"25/10,":[64],"25/25,":[65],"50/25,":[66],"50/50,":[67],"75/50,":[68],"75/75":[70],"micrograms/m2":[71,195,201],"per":[72],"day":[73],"rTNF-alpha/rIFN-gamma.":[75],"A":[76,212],"minimum":[77],"entered":[82],"sequentially":[83],"at":[84,119],"each":[85],"level.":[87],"If":[88],"the":[89,98,103,109,140,266],"first":[90],"2-week":[91,111],"cycle":[92],"was":[95,100,193,220,232],"well":[96],"tolerated,":[97],"increased":[101],"to":[102,126,134,174,186,225],"next":[104],"highest":[105],"level":[107],"during":[108],"second":[110],"cycle.":[112],"Fever,":[113],"chills,":[114],"fatigue":[116],"observed":[118],"all":[120],"doses.":[121],"Severity":[122],"symptoms":[124],"corresponded":[125],"increasing":[127],"levels.":[129],"Although":[130],"TNF":[131],"is":[132],"identical":[133],"molecule":[136],"known":[137],"as":[138],"\"cachectin,\"":[139],"vast":[141],"majority":[142],"our":[144],"did":[146],"not":[147],"lose":[148],"weight":[149],"while":[150],"on":[151],"study.":[152],"However,":[153],"alterations":[154],"lipid":[156],"metabolism":[157],"occurred":[158],"manifested":[161],"median":[164,250],"change":[165],"triglyceride":[167],"values":[168,180],"+40":[170],"mg/dl":[171,183],"(range,":[172,184,254],"-130":[173],"+318":[175],"mg/dl),":[176],"cholesterol":[179],"-30":[182],"-103":[185],"+2":[187],"mg/dl).":[188],"maximum":[190],"tolerated":[191],"75":[194],"combined":[198],"50":[200],"rIFN-gamma,":[203],"dose-limiting":[205],"side":[206],"effects":[207],"being":[208],"mainly":[209],"constitutional":[210],"symptoms.":[211],"dose-related":[213],"suppression":[214],"granulocyte":[216],"platelet":[218],"counts":[219],"observed.":[221],"Hematologic":[222],"parameters":[223],"returned":[224],"baseline":[226],"within":[227],"72":[228],"h":[229],"after":[230],"discontinued,":[233],"neither":[235],"infection":[236],"nor":[237],"bleeding":[238],"occurred.":[239],"Ten":[240],"22":[242],"evaluable":[243],"had":[245],"stable":[246],"disease":[247],"8":[252],"4-21":[255],"weeks);":[256],"12":[257],"showed":[259],"progressive":[260],"disease.":[261],"This":[262],"will":[264],"form":[265],"framework":[267],"phase":[269],"II":[270],"trials":[271],"therapy.":[277]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}